Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Pain Sensitivity and Pruritus of Peripheral Nerves

5 november 2026 uppdaterad av: Silvia Lo Vecchio, Aalborg University

Pain Sensitivity and Pruritus of Peripheral Nerves - Can we Differentiate These Signals by Use of Pharmacological Modulation and Human Experimental Research?

Previous research has demonstrated that itch and pain share several underlying neural pathways and signaling molecules. Understanding these common mechanisms is important for developing more effective therapeutic strategies targeting both sensations. Mepyramine, an antihistamine, has been reported to exert effects on both itch and pain perception. This study aims to investigate these effects using established experimental models of itch and pain. Itch will be induced using histamine, a naturally occurring substance in the human body, and spicules from the plant Mucuna pruriens (cowhage), while electrical stimulation will be used to assess pain-related responses. By combining these experimentais approaches, the project aims to better understand how mepyramine influences different sensory mechanisms. The overall purpose of this study is to evaluate the effects of mepyramine on experimentally induced itch and pain in healthy volunteers.

Studieöversikt

Studietyp

Interventionell

Inskrivning (Faktisk)

20

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Aalborg
      • Gistrup, Aalborg, Danmark, 9260
        • Center for Neuroplasticity and Pain Faculty of Medicine, Aalborg University Selma Lagerløfs Vej 249 9260 Gistrup, Denmark

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 60 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Healthy men and women aged 18-60 years
  • Speak and understand English

Exclusion Criteria:

  • Pregnancy or lactation

  • Drug addiction defined as any use of cannabis, opioids, or other drugs that may cause addiction.

  • History of peripheral or chronic pain conditions, neuropathy, neurological, dermatological, or psychiatric diagnoses that may affect the results.

    • Moles, wounds, scars, or tattoos in the area to be treated or tested
    • Current use of medications that may affect the trial such as antihistamines, painkillers, antidepressants, or anticonvulsants
    • Use of antihistamines should be discontinued 72 hours before the experiment and all topical agents and emollients should be discontinued 24 hours before the experiment.
    • Application of moisturizing lotion of the volar site of the forearms (24 hours before study start)
    • Previous traumatic experience of an electrical accident
    • Participation in any other research projects/studies 7 days before study start
    • Known allergy/intolerance to mepyramine
    • The subject is assessed as unable to engage in the necessary cooperation required by the study

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Grundläggande vetenskap
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Interventions

This subproject will be conducted in one single session lasting approximately 4-5 hours. In each forearm of the participant, two 4x4 cm areas will be selected as Area of Interest (AOI). In these selected areas, the same cream will be applied for 1 hour. After the cream removal, itch will be induced using histamine and cowhage (the order of histamine and cowhage will be randomized). During the application of the substances, the itch/pain elicited will be monitored for 10 minutes using a VAS (Visual analog scale). After the removal of the substances, measurements of SBP, MEI, PTT MPT, MPS, and thermal sensitivity will be conducted.

About 30 spicules will be applied on the selected areas and inserted manually

Mepyramine cream 2%

One drop of histamine will be applied on the selected areas and pierced with a lancet.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Measuring itch by computerized Visual Analog Scale Scoring
Tidsram: During Histamine/cowhage application

We will ask the subjects to rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates

During Histamine/cowhage application
Superficial blood perfusion
Tidsram: Before pruritogen application
Before pruritogen application
Superficial blood perfusion
Tidsram: 1 minute after pruritogen removal
1 minute after pruritogen removal
Superficial blood perfusion
Tidsram: 1 minute after cream+pruritogen removal
1 minute after cream+pruritogen removal
Perception threshold tracking model (PTT)
Tidsram: Before cream application
Before cream application
Perception threshold tracking model (PTT)
Tidsram: 1 minute after cream removal
1 minute after cream removal

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Mechanically evoked itch (MEI)
Tidsram: 2 minute after pruritogen removal

MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force).

2 minute after pruritogen removal
Mechanically evoked itch (MEI)
Tidsram: 2 minute after cream+pruritogen removal

MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force).

2 minute after cream+pruritogen removal
Mechanical Pain Thresholds (MPT)
Tidsram: 5 minute after pruritogen removal

This test is conducted using a pinprick set. The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN.

5 minute after pruritogen removal
Mechanical Pain Thresholds (MPT)
Tidsram: 5 minute after cream+pruritogen removal

This test is conducted using a pinprick set. The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN.

5 minute after cream+pruritogen removal
Mechanical Pain Sensitivity (MPS)
Tidsram: 8 minute after pruritogen removal

This test is conducted with the same pinprick set used to test the MPT.

8 minute after pruritogen removal
Mechanical Pain Sensitivity (MPS)
Tidsram: 8 minute after cream+pruritogen removal

This test is conducted with the same pinprick set used to test the MPT.

8 minute after cream+pruritogen removal
Cold Detection Thresholds (CDT)
Tidsram: 10 minute after pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after pruritogen removal
Cold Detection Thresholds (CDT)
Tidsram: 10 minute after cream+pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after cream+pruritogen removal
Warm Detection Thresholds (WDT)
Tidsram: 10 minute after pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after pruritogen removal
Warm Detection Thresholds (WDT)
Tidsram: 10 minute after cream+pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after cream+pruritogen removal
Cold Pain Thresholds (CPT)
Tidsram: 10 minute after pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after pruritogen removal
Cold Pain Thresholds (CPT)
Tidsram: 10 minute after cream+pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after cream+pruritogen removal
Heat Pain Thresholds (HPT)
Tidsram: 10 minute after pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after pruritogen removal
Heat Pain Thresholds (HPT)
Tidsram: 10 minute after cream+pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after cream+pruritogen removal
Pain to Supra-threshold Heat Stimuli (STHS)
Tidsram: 10 minute after pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after pruritogen removal
Pain to Supra-threshold Heat Stimuli (STHS)
Tidsram: 10 minute after cream+pruritogen removal

The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device

10 minute after cream+pruritogen removal

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

15 oktober 2026

Primärt slutförande (Beräknad)

31 december 2027

Avslutad studie (Beräknad)

31 december 2028

Studieregistreringsdatum

Först inskickad

15 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

15 oktober 2026

Första postat (Faktisk)

22 oktober 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

9 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

5 november 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera